Benzinga | Oct 26, 2021 05:39AM EDT

Alterity Therapeutics Granted U.S. Patent #11,155,547 'Compounds for and methods of treating diseases'

AbstractThe present invention provides heterocyclic compounds of formula (I) that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to compounds that modulate iron and to compounds for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA). ##STR00001##

View patent here